Ashley Hay, BSN, RN

Patient experience webinar

Patient experience webinar

The need for transformation in the
healthcare industry remains unequivocal;
however, progress has been slow. Change
is being driven by rising healthcare costs,
public health crises exacerbated by
COVID-19, and the acceleration of health
equity initiatives to address systemic
inequities...

For years, Fabry disease was often seen as a "man's disease." In this webinar, a group of women discuss topics around the unique set of challenges they've faced, from the struggle for acceptance, to overcoming barriers to proper care, to family planning and managing guilt associated with passing on this genetic disease.

Women in medicine continue to face gender biases and an existing wage gap in the workplace. Overcoming these gender-based biases can be taxing, more so when attempting to navigate any changes as a single physician, particularly within a large institution. Mentorship support can be critical to success and a sustainable career.
The American Society of Clinical Oncology (ASCO) presented a survey at its 2021 annual meeting showing that 79% of females working in the oncology sector experienced gen...

The American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) have jointly released new Oncology Medical Home (OMH) guidelines to standardize the definition of high-quality oncology care.
ASCO and COA hope that the new standards will instill a framework focused on high-quality, patient-centric, and value-based care. A multidisciplinary panel of experts assisted in developing the published guidance; the team was comprised of experts in various areas of patient advo...

The director of the Division of Cancer Survivorship at St. Jude Children's Research Hospital believes that education for survivors is vital

Melissa M. Hudson, MD, director of the Division of Cancer Survivorship at St. Jude Children's Research Hospital, recalls that her interest in science began at a young age. “I remember talking about medicine since I was in junior high school,” she says. She also remembers her delight upon recently finding a paper about becoming a pediatrician that she had ...

Chemotherapy involves the use of chemicals that target cancer cells, which is a standard treatment for some types of breast cancer. The goal of chemotherapy, or chemo, is to improve overall survival. In some cases, however, it may be prescribed to simply provide comfort care—not allowing the tumor to get too big, which can cause other discomforts in certain cases.
Chemotherapy has been associated with potential side effects, some of which are severe. Healthcare providers are knowledgeable of ...

Chest X-rays were often ordered as part of the breast cancer staging process. Today, this type of imaging test may or may not be one you receive prior to treatment.
Chest X-rays have limitations in detecting if breast cancer has spread. However, your healthcare provider may still recommend a chest X-ray for several reasons, such as infection.
This article will review the purpose, risks, and limitations of X-rays for breast cancer staging, as well as what you can expect before, during, and aft...

Dr. Steven G Eisenberg

Updates to guidelines suggest patient care improvements

As director of the National Cancer Institute, Dr. Sharpless has turned a passion for research into a lifelong career

Chemotherapy can cause a number of side effects. While not the most serious of side effects, hair loss can certainly be one of the most distressing. It is important to note that not all types of chemo cause hair loss.
Chemotherapy may also affect hair regrowth. Toward the end of treatment or soon after you have completed your last round of chemotherapy, your hair will start to come back. But when it returns, the texture and color may be completely different from your original hair.1
This is t...

According to a recent study published in the Journal of Genetic Counseling, barriers to care for women with a high risk of breast cancer include a multitude of cost-associated factors, even when those patients are covered by health insurance.1 The findings illustrate a critical need for health care pricing transparency to detect and treat cancer early.
Qualitative interviews were conducted with 50 female patients to assess various aspects of financial constraints, including a lack of medical ...

At the 2021 annual meeting of the American Society of Clinical Oncology, positive data from several phase 3 clinical trials indicated an earlier role for novel therapeutic treatments for patients with metastatic disease. The studies suggest that adjuvant therapy with newer agents may increase disease-free survival in a range of tumor types and benefit select subsets of patients with a higher risk of recurrence after primary treatment.
The results of 4 clinical trials in total were presented; ...